Get Blog Posts Directly In Your Inbox

Your email:

Follow BBCR

Current Articles | RSS Feed RSS Feed

Do you have a Clinical Development Plan?

 
ClinicalDevelopmentPlan
Earlier, we talked about how proper Clinical Trial Planning and Strategy can save pharma companies time and money. We wanted to talk more about a clinical development plan and its importance, especially for early-stage clinical development companies.

Why do we need a Clinical Development Plan?
Well, many biotech and pharmaceutical companies, especially that are new in the industry, have limited clinical development experience. This puts them at a disadvantage as they do not foresee the future challenges and problems that they would face during the development period. Many experts cite poor planning as the most common reason for clinical development trials going over budget, costing more than expected and sometimes just abandoned because of lack of resources, wasting all the effort spent.

What is the Scope of a Clinical Development Plan?
The clinical development plan generally focuses on the early phases of drug development. It outlines the hypothesis that the trial is going to test and the study methodology that would be used to test the hypothesis. Defining the hypothesis is very important as it helps in identifying decision points in the study which would invalidate the hypothesis - indicating that the study objectives should be re-evaluated. An optimal clinical trial design is planned to flag safety an efficacy concerns as early as possible in the trial, helping save the company time and money.

Other than the hypothesis and outline of the study, a good Clinical Development Plan should clearly define:
  • Time needed to conduct individual studies with all the milestones clearly defined with entry and exit criteria
  • Amount and type of resources required for each trial. It should clearly identify the level of expertise required to conduct individual tasks
  • Amount and quality of data that should be collected and analyzed as part of each trial. As we discussed earlier, many companies with less experience in clinical development tend to collect a lot of redundant data (because they don't plan ahead regarding what data is relevant to their study) and then end up wasting a lot of time cleaning and figuring out what to do with it and how to analyze all the data
  • Risks and the mitigation plan - financial for not meeting the study enpoints

Does your company spend enough time on designing a clinical development plan before jumping into the trial? Please let us know your thoughts or contact us if you have any questions or need further information on Clinical Development Strategy and Planning.

Comments

Great backgrunder on the CDP. One add'l note - some companies consider the CDP as just one section or addendum to the more comprehensive IDP (Integrated Development Plan) - which spans all all R&D and even commercializatio of the product candidate. The IDP helps to focus and synch all functions that contribute to the development of the product.
Posted @ Monday, July 19, 2010 7:33 AM by Ed Campanaro
Thank you very much for your comment. It is a great one!! 
 
I couldn't agree more!! Indeed, the clinical development plan must be part of the drug development plan and fully integrated with it. Specifically, Integration is one of the main objective that Boston Biotech Clinical Research (BBCR) team has in mind while working on a clinical plan. Integration with the regulatory requirements (FDA and/or EMEA) are essential to get the product approved, and analysis of the marked with development of biomarkers and differentiating factors are crucial for positioning the new product and commercialization. 
 
I welcome more comments and suggestions that indicate what you want to read about and will be useful in your product's development. Please share your opinions, concerns and questions. 
 
cfratazzi@bostonclinicalresearch.com
Posted @ Tuesday, July 20, 2010 1:16 PM by Candida Fratazzi
Post Comment
Name
 *
Email
 *
Website (optional)
Comment
 *

Allowed tags: <a> link, <b> bold, <i> italics